Back to Newsroom

Clinical Trial Results Disclosure by Large Biopharmaceutical Companies Falls Below Legal and Ethical Standards, Study Published in BMJ Open Shows

Bioethics International, a not-for-profit organization focused on the ethics and governance of how medicines are researched, developed, marketed and made accessible to patients around the world, today announced the publication of a study ranking large pharmaceutical companies by transparency of clinical trial results in BMJ Open. In the study, only two-thirds of clinical trials per drug that supported new drug approvals in 2012 were disclosed, falling below legal and ethical standards. In addition, almost half of all reviewed drugs had at least one undisclosed Phase 2 or 3 trial.

Read more here.